Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative genomic analysis of 21 orofacial diseases identifies shared genetic architecture with systemic diseases.

Nature communications·2026
Same author

Topological Data Analysis of Spatial Protein Expression in Multiplexed Spatial Proteomics Studies.

bioRxiv : the preprint server for biology·2026
Same author

Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

Cancer discovery·2026
Same author

Discovery of gene-alcohol interaction loci influencing blood pressure in 1.1 million individuals from multiple populations.

Research square·2026
Same author

Gene-by-Sleep Duration Interaction for Glycemic Traits in over 480,000 Individuals.

medRxiv : the preprint server for health sciences·2026
Same author

Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.

Nature cancer·2026

Related Experiment Video

Updated: May 21, 2026

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Optimal tests for rare variant effects in sequencing association studies.

Seunggeun Lee1, Michael C Wu, Xihong Lin

  • 1Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA.

Biostatistics (Oxford, England)
|June 16, 2012
PubMed
Summary

A new optimal rare variant association test is introduced, outperforming existing burden tests and SKAT (Sequence Kernel Association Test). This powerful method enhances genetic studies by maximizing power across diverse variant scenarios.

More Related Videos

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Related Experiment Videos

Last Updated: May 21, 2026

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Area of Science:

  • Genetics
  • Statistical Genetics
  • Bioinformatics

Background:

  • Massively parallel sequencing necessitates advanced rare variant association tests.
  • Existing methods like burden tests and SKAT have limitations in detecting associations under various genetic models.
  • The direction and magnitude of variant effects are often unknown in biological contexts.

Purpose of the Study:

  • To develop a novel class of rare variant association tests that encompasses both burden tests and SKAT.
  • To derive an optimal test within this class that maximizes statistical power across different scenarios.
  • To provide tools for designing future sequence association studies, including sample size and power calculations.

Main Methods:

  • Proposed a flexible class of association tests including burden tests and SKAT as special cases.
  • Derived an optimal test by maximizing power within the proposed class.
  • Conducted simulation studies to evaluate the performance of the new test against existing methods.
  • Applied the test to triglyceride data from the Dallas Heart Study.
  • Derived sample size/power calculation formulas for SKAT with new kernels.

Main Results:

  • The proposed optimal test demonstrated superior performance compared to burden tests and SKAT in a wide range of simulated scenarios.
  • The new test is robust and powerful, particularly when the directionality and magnitude of variant effects are unknown or mixed.
  • The derived formulas facilitate the design of more efficient and powerful genetic association studies.

Conclusions:

  • The developed optimal test offers a significant advancement in rare variant association testing for complex diseases.
  • This approach provides a more powerful and flexible tool for geneticists and bioinformaticians analyzing sequencing data.
  • The findings will aid in identifying genetic variants associated with diseases and improving study design.